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ABSTRACT
Diabetes mellitus (DM) is a major risk factor for stroke, which is associated with unfavorable outcome after 
acute ischemic stroke (AIS) and disability. The potential harmful effect of DM, and the role and importance 
of blood glucose (BG) at admission  are currently unclear for a clinical outcome after АIS. The aim of this 
study is to look for correlations between the presence of DM and the initial level of BG, and the clinical out-
come after an intravenous thrombolysis (IVT) in patients with acute AIS.
MATERIALS AND METHODS: IVT with Astylise© was conducted on 170 patients with AIS in the pe-
riod September, 2011- September, 2015, of whom 20% (n=34) were with DM and 80% without DM (n=136). 
According to the values of the BG at admission  they were divided into three groups: group I - (n=34) <6.0 
mmol/l; group II (n=65) 6.1-8.0 mmol/l; group III (n=39) >8.1 mmol/l.
RESULTS: 60.2% of the patients without DM and 40% of those without, p= 0.05(OR-1.5, 95% CI 0.91-2.49), 
are with mRs (0-2) after 3 months, 35% and 24%, respectively, (p= 0.196), are with mRs (0-1). The proba-
bility of this outcome is 1.47 times higher in those without DM (OR 1,47, 95% CI: 0,7-3,09). Mortality at the 
third month is 20% in patients with DM and 8.8% in those without DM, p<0.05. The frequency of intrace-
rebral hemorrhage (ICH) is similar - 5.9% and 6.6% (p=0.617). There is no statistically reliable dependence 
between the clinical outcome after 3 months and blood sugar levels at admission. 64.7% of the patients in 
group I, 58.5% of those in group II, and 46.2% of those in group III (p>0.05) are with mRs (0-2). 38.2%, 
32.3% and 30.8% (p>0.05), respectively, are with mRs (0-1). Mortality is 15.4% in group III compared to 
9.2% in group II, and 8.8% in group I (p>0.05). 38.4% of the patients from group III and 26.5% from group 
I (p>0.05) are with mRs (3-5).
CONCLUSION: Patients with DM have significantly higher mortality and lack of favorable functional out-
come at the third month compared to those without DM, which cannot be explained by the presence of ICH. 
The initial HG is not significantly associated with an unfavorable clinical outcome, but it quickly identifies 
patients with an increased risk of such an outcome in whom the blood sugar levels should be closely moni-
tored.
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INTRODUCTION 
Diabetes mellitus (DM) is a major risk factor 
for stroke.In the recent decades its frequency has in-
creased progressively, especially among younger age 
groups (1). The frequency of AIS is 3-4 times high-
er in patients with DM compared to those without 
DM. The risk is highest in individuals under 65 years 
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of age (2). DM is associated with an unfavorable out-
come after AIS and a disability (3). In 20-50% of the 
cases with AIS hyperglycemia (HG) is established at 
admission, even without a prior history of DM (4). 
HG is a significant clinical problem. Nowadays, the 
potential harmful effects of DM, and the role and im-
portance of BG at admission are unclear for the clini-
cal outcome after AIS and are a subject of research in 
several studies. Studies on animal models show that 
induced HG in rats causes a delayed recovery of ce-
rebral blood flow in the ischemic hemisphere and in-
crease of the attacked zone (5). Persistent HG is asso-
ciated with an unfavorable clinical outcome and in-
creased mortality (6,7). The increased production of 
thrombin HG leads to increased coagulation (8). HG 
also causes increased production of the plasminogen 
activator inhibitor (PAI -1) (9). Due to the harmful 
effect on the neurons it compromises the positive ef-
fect of reperfusion after IVT (10). Acute HG leads to a 
larger delay of the reperfusion of the penumbra than 
the chronic one (11). The aim of this study is to look 
for correlations between the presence of DM and the 
initial level of blood sugar, and the clinical outcome 
after IVT.
MATERIALS AND METHODS
In the period September, 2011- September, 
2015, IVT was conducted on 170 patients with acute 
AIS, of which 20% (n=34) have a history of DM. 
Their clinical outcome was compared with that of 
patients without DM (n=136 ). According to the val-
ues of the initial blood sugar, the patients were divid-
ed into three groups: group I - (n=34) <6.0 mmol/l; 
group II (n=65) 6.1-8.0 mmol/l; group III (n=39) >8.1 
mmol/l. IVT with Actylise© was conducted by an 
established protocol in accordance with the exist-
ing standards and criteria in the presence of inclu-
sion criteria and the absence of contraindications. A 
total of 0.9 mg/kg body weight Actylise© of which 
10% bolus was applied in a continuous intravenous 
infusion for 60 min, and a maximum of 90mg. The 
National Institute of Health Stroke Scale (NIHSS), 
a grading scale, was applied to assess the severity of 
the focal neurological deficit. The functional inde-
pendence of the third month and the degree of dis-
ability were assessed by the modified Rankin (mRs) 
scale. CT examination of the head is done natively 
at admission and 24 hours after IVT. The laboratory 








Male 73 (53.7%) 14 (41.2%)
0.133
Female 63 (46.3%) 20 (58.8%)
HD 121 (89.0%) 32 (94.1%) 0.296
Dyslipidae-
mia
31 (22.8%) 9 (26.5%) 0.402
AF 47 (34.6%) 12 (35.3%) 0.543







NIHSS 13.8 (6-21) 14.1 (6-21) 0.736
ОТТ 182.1 (65-270) 188.5 (45-260) 0.490
Table 1. Clinical characteristics of patients with and with-
out DM
panel includes blood count, serum glucose at admis-
sion, BSP, total cholesterol, LDL, HDL, INR, APTT.
RESULTS
The mean age of patients without DM (n=136) 
was 68.4 years (±12,1), and of those with DM (n=34) 
- 70.4 years (±10,2 ) with a slight prevalence of wom-
en (58.8%). The frequency of vascular risk factors is 
similar or the difference is statistically insignificant. 
Only the systolic blood pressure (SBP) at admission 
was significantly higher in diabetics (154.1mmHg 
and 145.5mmHg, respectively, p = 0.024). Onset-to-
treatment time (OTT) and NIHSS were similar for 
both groups. The demographic and clinical signs are 
presented in (Table 1).
The favorable clinical outcome (mRs 0-2) at the 
third month is significantly more frequent in patients 
without DM compared to those with DM (60.2% and 
40%, respectively, p = 0.05). A logistic regression 
analysis demonstrated 1.5 times greater probabili-
ty for them of mRs (0-2) (OR-1.5, 95% CI 0.91-2.49). 
With a full recovery (mRs 0-1) are 35% of the patients 
without DM and 24% of those with DM (p=0.196). 
34 
Scripta Scientica Medica, vol. 48, No. 2, 2016, pp. 32-36 
Medical University of Varna
Impact of Diabetes Mellitus and Admission Hyperglycemia on Outcomes Aer Intravenous rombolysis in Acute Ischemic Stroke ...
The probability of this outcome is 1.47 times great-
er in those without DM (OR 1.47, 95% CI: 0.7-3.09). 
Mortality around the 3rd month is significantly 
higher in diabetics (20% vs. 8.8%, p<0.05). The fre-
quency of ICH is similar - 5.9% and 6.6%, respective-
ly (p=0.617). The results are presented in (Table 2).
There is no statistically proven dependence be-
tween the clinical outcome at the 3rd month and the 
admission BG, despite the high frequency of mRs (0-
2) in normal glycemic patients. They are 64.7% v/s 
58.5% in group II and 46.2% in group III (p>0.05). 
With mRs (0-1) are 38.2%, 32.3% and 30.8% (p>0.05), 
respectively. Mortality is higher in group III (15.4%), 
compared to 9.2% and 8.8% in the other two groups 
(p>0.05). 38.4% from group III and 26.5% (p> 0.05) 
from group I are with disability (mRs3-5). The re-
sults are presented in (Table 3) and (Fig. 1).
DISCUSSION 
In the present study, DM is associated with a 
significantly lower frequency of a favorable clinical 
outcome (mRs 0-2) and higher mortality at the 3rd 
month after AIS.The results are similar to those of 
a number of unadjusted studies (12,13). A signifi-
cant correlation between DM and ICH is not prov-
en. The predictive role of DM for the clinical out-
come after IVT remains currently undefined. Ac-
cording to some authors DM is significantly asso-
ciated with an increased risk of SICH (symptomat-
ic intracerebral hemorrhage) (14). After IVT, the in-
sulin resistance correlates with an unfavorable long-
term clinical outcome (15). Analysis of the results 
from SITS-ISTR indicates an increased risk of mor-
tality or an unfavorable outcome at the 3rd month af-
ter AIS in patients with DM, while the frequency of 
ICH is similar in those with and without DM (16). A 
recent study indicates an association between acute 
or chronic HG and higher risk of mortality and unfa-
vorable outcome, despite previously diagnosed DM. 
The dependence is nonlinear, with a plateau of about 
200 mg/dl and HbA1C - 8% (17). One possible ex-
planation for the negative effect of HG is the comor-
bidity caused by DM. The unfavorable prognosis of 
AIS with concomitant DM depends on many fac-
tors - diabetic neuropathy, formation and accumu-
lation of lactate, anaerobic metabolism in a HG (18). 
In the present study the initial HG does not correlate 
significantly with deteriorated clinical outcomes or 






р OR(95 % CI)
mRS 0-2* 68 (60.2%) 10(40.0%) 0.05 1.5 (0.91-2.49)
mRS 0-1 40 (35.4%) 6 ( 24.0%) 0.196 1.47 (0.70-3.09)
mRS 6* 10 (8.80%) 5 (20.0%) <0.05 0.44 (0.16-1.18)
ICH 9 (6.6 %) 2 (5.9%) 0.617 1.13 (0.25-4.96)









mRs 0-2 22 (64.7%) 38 (58.5%) 18 (46.2%) >0.05
mRs 0-1 13 (38.2%) 21(32.3%) 12( 30.8%) >0.05
mRs 6 3 (8.8%) 6 (9.2%) 6 (15.4%) >0.05
Table 3. Three-month clinical outcome according to blood glucose values at admission
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maximum HG and average HG are independent pre-
dictors of the clinical outcome and HG at admis-
sion is not an indicator of an unfavorable outcome 
(19). Post-hoc analysis of the results of the NINDS 
demonstrates that BG at admission correlates with 
an unfavorable functional outcome and occurrence 
of SICH. The dependence is linear, the risk increas-
es 1.75 times for every 100 mg/dl increase, regardless 
of the severity of AIS and the history of DM (20). An-
other study establishes a significant correlation be-
tween HG at admission and SICH, mortality and un-
favorable functional outcome at the 3rd month, as it is 
debatable whether HG directly damages the ischemic 
brain tissue, or it is an epiphenomenon of the gravi-
ty of AIS. A dose-dependent correlation between HG 
and the unfavorable clinical response remains still 
assumed only (21). The exact mechanisms by which 
HG influences the unfavorable clinical outcome af-
ter AIS are different and not well studied. They may 
be a distortion of the blood-brain barrier and an in-
creased risk of hemorrhagic transformation (22). In-
creased production of free radicals, mitochondrial 
damage, cellular edema, and influx of extracellular 
Са²+ are also pathological damaging processes in the 
presence of HG (23). In the acute phase of AIS, HG at 
admission is a stress reaction in which, as a result of 
the involvement of the hypothalamic-pituitary-adre-
nal system, cortisol and catecholamines are excreted, 
and DM is a response to the gravity of the AIS (24).
CONCLUSION 
Patients with DM have a significantly high-
er mortality rate and a lack of favorable functional 
outcome at the third month compared to those with-
Fig. 1. Distribution of all clinical outcomes based on blood 
glucose values at admission
out DM, which cannot be explained by the presence 
of ICH. The BG at admission is not significantly as-
sociated with an unfavorable clinical outcome, but it 
quickly identifies patients with an increased risk of 
such an outcome in whom BG levels should be close-
ly monitored.
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